Jones Mitchell Lawrence
See Remarks
Jones Mitchell Lawrence has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Oct 8, 2026.
On the most recent filing, Jones Mitchell Lawrence is listed as Chief Medical Officer at PALISADE BIO, INC. Inside the rolling window, Jones Mitchell Lawrence reported no open-market purchases and 2 open-market sales totaling $110K in PALI. The largest disclosed transaction in the window is a sale of 51,880 PALI shares on Jul 7, 2026, worth $107K.
Companies traded
Other insiders at PALI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$110K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Jones Mitchell Lawrence made?
Jones Mitchell Lawrence has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Jones Mitchell Lawrence trade?
Jones Mitchell Lawrence has filed SEC Form 4 disclosures for 1 company, including PALI.
When was Jones Mitchell Lawrence's most recent SEC Form 4 filing?
Jones Mitchell Lawrence's most recent SEC Form 4 filing on Tracefour is dated Oct 8, 2026.
What is Jones Mitchell Lawrence's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Jones Mitchell Lawrence is listed as See Remarks.
What is Jones Mitchell Lawrence's total buy and sell value in the current window?
Inside the rolling retention window, Jones Mitchell Lawrence bought $0 and sold $110K based on SEC Form 4 filings.
What was Jones Mitchell Lawrence's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 51,880 PALI shares on 2026-07-07, worth $107K, per SEC Form 4 filings.